Active substance | Somatropin |
---|---|
Water Retention | No significant effect |
Hepatotoxicity | Rare, but cases of severe liver injury reported |
Lab Test | Monitoring of liver enzymes may be advised |
Also known as | Orlistat |
Blood pressure | No significant impact |
Trade name | Orlistat, marketed under the trade name Xenical among others |
Storage conditions | Store at 25°C (77°F), exceptions permitted to 15–30°C (59–86°F) |
Chemical name | Tetrahydrolipstatin |
Formula | C29H53NO5 |
Substance class | Lipase inhibitor |
Main action | Prevents the absorption of fats from the human diet, thereby reducing caloric intake |
Half-life | 1 to 2 hours |
Dosage (medical) | 120 mg orally three times/day with each main meal containing fat |
Dosage (sports) | Not recommended for sports usage |
Effects | Reduces the absorption of dietary fats |
Side effects | Oily spotting, flatulence, fecal urgency, soft stools, fecal incontinence |
Use in sports | Not typically used in sports |
Active ingredient, IU | 102 |
Release form | Vial |
1 Vial, IU | 102 |
Vials in the package, pcs | 1 |
Manufacturer | MGT |
Reviews
There are no reviews yet.